Proralone-Mop en es it fr

Proralone-Mop Brand names, Proralone-Mop Analogs

Proralone-Mop Brand Names Mixture

  • No information avaliable

Proralone-Mop Chemical_Formula

C12H8O4

Proralone-Mop RX_link

http://www.rxlist.com/cgi/generic2/methox.htm

Proralone-Mop fda sheet

Proralone-Mop FDA

Proralone-Mop msds (material safety sheet)

Proralone-Mop Synthesis Reference

No information avaliable

Proralone-Mop Molecular Weight

216.19 g/mol

Proralone-Mop Melting Point

No information avaliable

Proralone-Mop H2O Solubility

No information avaliable

Proralone-Mop State

Solid

Proralone-Mop LogP

2.336

Proralone-Mop Dosage Forms

Liquid

Proralone-Mop Indication

For the treatment of psoriasis and vitiligo

Proralone-Mop Pharmacology

Methoxsalen selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Methoxsalen-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.

Proralone-Mop Absorption

No information avaliable

Proralone-Mop side effects and Toxicity

No information avaliable

Proralone-Mop Patient Information

Patients should be told emphatically to wear UVA-absorbing, wrap-around sunglasses and cover exposed skin or use a sunblock (SP 15 or higher) for the twenty-four (24) hour period following treatment with methoxsalen, whether exposed to direct or indirect sunlight in the open or through a window glass.

Proralone-Mop Organisms Affected

Humans and other mammals